(Q30915154)

English

A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

0 references

Linda Simoni-Wastila

1

object named as

Linda Simoni-Wastila

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

3

object named as

Connie Mah

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Dennis Ross-Degnan

2

object named as

Dennis Ross-Degnan

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Peter Gallagher

8

object named as

Peter Gallagher

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Stephen B Soumerai

10

object named as

Stephen B Soumerai

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

author name string

Xiaoming Gao

4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Jeffrey Brown

5

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Leon E Cosler

6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Thomas Fanning

7

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Carl Salzman

9

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

322-336

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of benzodiazepine prescribing practices: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Benzodiazepines in the treatment of schizophrenia: an updated survey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A risk-benefit assessment of pharmacological treatments for panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in the medical treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Examining product risk in context. Market withdrawal of zomepirac as a case study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Appropriate Use and Regulatory Control of Benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of benzodiazepines in anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Seizures following the withdrawal of alprazolam

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal phenomena after long-term administration of benzodiazepines. A review of recent investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal reaction after long-term therapeutic use of benzodiazepines.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clorazepate and lorazepam: clinical improvement and rebound anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(04)90030-6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

release_bnbos3g75raz7pgl4jn5ppniu4

1 reference

https://api.fatcat.wiki/v0/release/bnbos3g75raz7pgl4jn5ppniu4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30915154&oldid=2075044168"